Avishay Sella - Concepedia

Author

Avishay Sella

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

A SELLA, A Sella, A. SELLA, A. Sella, AVISHAY SELLA, Ana Beatriz Afonso Sella, Avishay Sella, Dimitrios Mavroudis, Keren Rouvinov, Monique Roobol

180

Publications

7.7K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Assaf Harofeh Medical Center Tel Aviv University Rabin Medical Center Rambam Health Care Campus

About

Avishay Sella is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	35	3.3K
2	Health Sciences	2	2	637
3	Natural Sciences	1	1	30
4	Public Health	1	1	45
5	Allergy	1	1	45

Avishay Sella

Publications

6.6K

Citations

H-Index

Page 1

	Year	Citations
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017 Silke Gillessen, Gerhardt Attard, Tomasz M. Beer, European Urology	2017	636
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu, The Lancet Oncology First-line TherapyUrologyChemotherapy Versus ChemotherapyGenitourinary CancerMedicine	2021	627
A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors. C. Logothetis, F. H. Dexeus, Laura Finn, Journal of Clinical Oncology Urological ResearchUrologyGenitourinary CancerMvac-treated PatientsMvac Chemotherapy	1990	616
Cabozantinib in Patients With Advanced Prostate Cancer: Results of a Phase II Randomized Discontinuation Trial David C. Smith, Matthew R. Smith, Christopher J. Sweeney, Journal of Clinical Oncology	2012	442
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015 Silke Gillessen, Aurelius Omlin, Gerhardt Attard, Annals of Oncology	2015	319
Sarcomatoid renal cell carcinoma: Clinicopathologic. A study of 42 cases Jae Y. Ro, Alberto G. Ayala, Avishay Sella, Cancer UrologyTumoral PathologyGenitourinary CancerMedicineSurgical Pathology	1987	250
Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapy Cora N. Sternberg, Fabio Calabr�, Giorgio Pizzocaro, Cancer	2001	208
Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: an update. C. Logothetis, Douglas E. Johnson, Clayton Chong, Journal of Clinical Oncology Surgical OncologyCancer ManagementAdjuvant ChemotherapyPathologyPharmacotherapy	1988	164
Chemotherapy for Small Cell Carcinoma of Prostatic Origin Robert J. Amato, Christopher J. Logothetis, Rebecca Hallinan, The Journal of Urology UrologyGenitourinary CancerMedicineProstatic OriginSmall Cell Carcinoma	1992	162
Genetic Abnormalities in Men with Germ Cell Tumors Francisco H. Dexeus, Christopher J. Logothetis, Clayton Chong, The Journal of Urology InfertilityUrologyGerm CellGenitourinary CancerCytogenetics	1988	149

Page 1